Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Tax Provisions: 2020-2024

Historic Tax Provisions for Revolution Medicines (RVMD) over the last 1 years, with Dec 2024 value amounting to -$800,000.

  • Revolution Medicines' Tax Provisions fell 333.24% to -$800,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$4.4 million, marking a year-over-year decrease of 12.75%. This contributed to the annual value of -$800,000 for FY2024, which is 77.30% up from last year.
  • According to the latest figures from Q4 2024, Revolution Medicines' Tax Provisions is -$800,000, which was down 333.24% from $343,000 recorded in Q4 2023.
  • In the past 5 years, Revolution Medicines' Tax Provisions registered a high of $362,000 during Q4 2020, and its lowest value of -$3.9 million during Q3 2023.
  • For the 3-year period, Revolution Medicines' Tax Provisions averaged around -$948,800, with its median value being -$297,000 (2022).
  • Examining YoY changes over the last 5 years, Revolution Medicines' Tax Provisions showed a top increase of 378.86% in 2023 and a maximum decrease of 1,202.02% in 2023.
  • Quarterly analysis of 4 years shows Revolution Medicines' Tax Provisions stood at $362,000 in 2020, then reached -$123,000 in 2022, then surged by 378.86% to $343,000 in 2023, then crashed by 333.24% to -$800,000 in 2024.
  • Its last three reported values are -$800,000 in Q4 2024, $343,000 for Q4 2023, and -$3.9 million during Q3 2023.